Abstract: The present invention relates to cancer markers. In particular, the present invention provides metabolites that are differentially present in prostate cancer.
Type:
Application
Filed:
August 2, 2013
Publication date:
February 20, 2014
Applicants:
METABOLAN INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Inventors:
Arul M. Chinnaiyan, Arun Sreekumar, Matthew W. Mitchell, Kay A. Lawton, Alvin Berger, Christopher Beecher